US Patent 8410051 FGF21 mutants and uses thereof
Patent 8410051 was granted and assigned to Amgen on April, 2013 by the United States Patent and Trademark Office.
All edits
Edits on 30 May, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 29 Nov, 2023
Golden AI
Edits made to:
Article (+306 characters)
Article
Patent abstract
The invention provides nucleic acid molecules encoding FGF21 mutant polypeptides, FGF21 mutant polypeptides, pharmaceutical compositions comprising FGF21 mutant polypeptides, and methods for treating metabolic disorders using such nucleic acids, polypeptides, or pharmaceutical compositions.
Edits on 21 Sep, 2023
Golden AI
Edits made to:
Infobox (+8 properties)
Infobox
Patent Inventor Names
Agnes Eva Hamburger0
Edward John Belouski0
Jeonghoon Sun0
Jing Xu0
Mark Leo Michaels0
Murielle Marie Ellison0
Randy Ira Hecht0
Yue-Sheng Li0
Edits on 7 Sep, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Edits on 7 Jun, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 20 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 08410051 FGF21 mutants and uses thereof US Patent 8410051 FGF21 mutants and uses thereof
Infobox
Patent Number
084100510
Patent Number
84100510
Edits on 25 Mar, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
084100510
Date of Patent
April 2, 2013
0Patent Application Number
131965440
Date Filed
August 2, 2011
0Patent Primary Examiner
Edits on 16 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 08410051 FGF21 mutants and uses thereof
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
08410051
Date of patent
April 2, 2013
Patent application number
13196544
Date Filed
August 2, 2011
Patent primary examiner
Find more entities like US Patent 8410051 FGF21 mutants and uses thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
